European HIV/AIDS Diagnostics Market 2014: Hospitals, Blood Banks, Public Health Labs, Commercial Labs--Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT Procedures

Complete report $3,950.  DataPack (test volumes, sales forecasts, supplier shares) $2,500.

Summary

This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK).  For each country, the report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments:

     - Hospitals

     - Commercial/Private Laboratories

     - Blood Banks

     - Public Health Laboratories

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.

Highlights

    Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.

    Examines market applications of Molecular Diagnostics, Immundiagnostics, IT and other emerging technologies.

    Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho- Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.

    Profiles leading manufacturers and potential market entrants developing innovative technologies and products.

    Analyzes alternative market penetration strategies for suppliers.

Methodology

The report is based on a combination of primary and secondary information sources, including Venture Planning Group’s proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments.  The database contains information on companies, technologies, products and executives worldwide.  Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.

Contains 277 pages and 31 tables